Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, et al. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo- Lancet 2021 Dec 23. pii: S0140-6736(21)02753.
PMID: 34953526